Insiders Updates Understanding the Risks of Investing in Larimar Therapeutics Inc (LRMR) Larimar Therapeutics Inc’s filing revealed that its Director Flynn James E acquired Company’s shares for reported $30.0 million on Jul
Insiders Updates Sharp decrease in LRMR’s short interest leads to decline in days-to-cover ratio Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Larimar Therapeutics